Quest Diagnostics Inc (DGX) Current Ratio
- Current ratio · latest quarter: Value 1.59×; Formula and calculation Current assets / current liabilities..
Current ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Current ratio · latest quarter | 1.59× | Current assets / current liabilities. $2.84B ÷ $1.79B ≈ 1.59× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Current assets | 2.84B USD | Assets, Current |
| Current obligations | 1.79B USD | Liabilities, Current |
| Cash and equivalents | 626.00M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Customer receivables | 1.67B USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory | 233.00M USD | Inventory, Net |
| Payables | (m) | |
| Borrowing debt due within one year | 10.00M USD | Long-term Debt, Current Maturities |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Current assets (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory (USD) | Payables (USD) | Borrowing debt due within one year (USD) | Current ratio |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $2.84B | $1.79B | $626.00M | (m) | $1.67B | $233.00M | (m) | $10.00M | 1.59× |
| 2026-03-31 | $2.57B | $2.18B | $393.00M | (m) | $1.59B | $225.00M | (m) | $503.00M | 1.18× |
| 2025-12-31 | $2.38B | $2.28B | $420.00M | (m) | $1.41B | $189.00M | (m) | $504.00M | 1.04× |
| 2025-09-30 | $2.41B | $2.13B | $432.00M | (m) | $1.46B | $186.00M | (m) | $504.00M | 1.13× |
| 2025-06-30 | $2.20B | $2.02B | $319.00M | (m) | $1.42B | $187.00M | (m) | $504.00M | 1.09× |
| 2025-03-31 | $2.08B | $1.44B | $188.00M | (m) | $1.40B | $189.00M | (m) | $1.00M | 1.44× |
| 2024-12-31 | $2.39B | $2.17B | $549.00M | (m) | $1.30B | $188.00M | (m) | $602.00M | 1.10× |
| 2024-09-30 | $2.62B | $2.09B | $764.00M | (m) | $1.38B | $184.00M | (m) | $603.00M | 1.25× |
| 2024-06-30 | $2.02B | $2.01B | $271.00M | (m) | $1.32B | $182.00M | (m) | $606.00M | 1.00× |
| 2024-03-31 | $2.23B | $2.30B | $474.00M | (m) | $1.32B | $181.00M | (m) | $906.00M | 0.97× |
| 2023-12-31 | $2.37B | $1.81B | $686.00M | (m) | $1.21B | $190.00M | (m) | $303.00M | 1.31× |
| 2023-09-30 | $1.81B | $1.62B | $143.00M | (m) | $1.28B | $184.00M | (m) | $304.00M | 1.12× |
| 2023-06-30 | $1.73B | $1.88B | $126.00M | (m) | $1.24B | $184.00M | (m) | $518.00M | 0.92× |
| 2023-03-31 | $1.81B | $1.35B | $175.00M | (m) | $1.25B | $190.00M | (m) | $2.00M | 1.34× |
| 2022-12-31 | $1.90B | $1.55B | $315.00M | (m) | $1.20B | $192.00M | (m) | $2.00M | 1.22× |
| 2022-09-30 | $2.33B | $1.60B | $700.00M | (m) | $1.28B | $183.00M | (m) | $2.00M | 1.46× |
| 2022-06-30 | $2.43B | $1.58B | $790.00M | (m) | $1.29B | $187.00M | (m) | $2.00M | 1.54× |
| 2022-03-31 | $2.48B | $1.70B | $712.00M | (m) | $1.37B | $197.00M | (m) | $2.00M | 1.46× |
| 2021-12-31 | $2.74B | $1.75B | $872.00M | (m) | $1.44B | $208.00M | (m) | $2.00M | 1.56× |
| 2021-09-30 | $2.85B | $1.76B | $987.00M | (m) | $1.47B | $205.00M | (m) | $1.00M | 1.62× |
| 2021-06-30 | $2.15B | $1.55B | $560.00M | (m) | $1.25B | $199.00M | (m) | $2.00M | 1.38× |
| 2021-03-31 | $3.00B | $1.71B | $1.23B | (m) | $1.38B | $223.00M | (m) | $2.00M | 1.76× |
| 2020-12-31 | $3.06B | $1.78B | $1.16B | (m) | $1.52B | $223.00M | (m) | $2.00M | 1.72× |
| 2020-09-30 | $3.35B | $2.39B | $1.60B | (m) | $1.42B | $205.00M | (m) | $555.00M | 1.40× |
| 2020-06-30 | $2.38B | $1.84B | $988.00M | (m) | $1.13B | $154.00M | (m) | $555.00M | 1.29× |
| 2020-03-31 | $1.56B | $1.13B | $342.00M | (m) | $972.00M | $126.00M | (m) | $3.00M | 1.38× |
| 2019-12-31 | $2.49B | $1.99B | $1.19B | (m) | $1.06B | $123.00M | (m) | $804.00M | 1.25× |
| 2019-09-30 | $1.78B | $2.01B | $434.00M | (m) | $1.12B | $112.00M | (m) | $805.00M | 0.88× |
| 2019-06-30 | $1.57B | $1.90B | $273.00M | (m) | $1.09B | $105.00M | (m) | $807.00M | 0.82× |
| 2019-03-31 | $1.78B | $2.28B | $464.00M | (m) | $1.08B | $98.00M | (m) | $1.11B | 0.78× |
| 2018-12-31 | $1.39B | $1.49B | $135.00M | (m) | $1.01B | $99.00M | (m) | $464.00M | 0.94× |
| 2018-09-30 | $1.60B | $1.39B | $263.00M | (m) | $1.10B | $95.00M | (m) | (m) | 1.15× |
| 2018-06-30 | $1.42B | $1.26B | $132.00M | (m) | $1.05B | $91.00M | (m) | (m) | 1.12× |
| 2018-03-31 | $1.37B | $1.12B | $124.00M | (m) | $1.03B | $94.00M | (m) | (m) | 1.23× |
| 2017-12-31 | $1.31B | $1.06B | $137.00M | (m) | $924.00M | $95.00M | (m) | $36.00M | 1.24× |
| 2017-09-30 | $1.54B | $1.05B | $350.00M | (m) | $960.00M | $100.00M | (m) | (m) | 1.47× |
| 2017-06-30 | $1.50B | $917.00M | $314.00M | (m) | $947.00M | $83.00M | (m) | (m) | 1.64× |
| 2017-03-31 | $1.56B | $985.00M | $367.00M | (m) | $960.00M | $77.00M | (m) | (m) | 1.58× |
| 2016-12-31 | $1.53B | $981.00M | $359.00M | (m) | $926.00M | $82.00M | (m) | $6.00M | 1.56× |
| 2016-09-30 | $1.64B | $1.05B | $406.00M | (m) | $966.00M | $82.00M | (m) | $7.00M | 1.57× |
| 2016-06-30 | $1.51B | $1.11B | $283.00M | (m) | $975.00M | $80.00M | (m) | $7.00M | 1.36× |
| 2016-03-31 | $1.49B | $1.09B | $128.00M | (m) | $952.00M | $82.00M | (m) | $158.00M | 1.37× |
| 2015-12-31 | $1.50B | $1.17B | $133.00M | (m) | $901.00M | $84.00M | (m) | $159.00M | 1.28× |
| 2015-09-30 | $1.65B | $1.13B | $123.00M | (m) | $914.00M | $86.00M | (m) | $160.00M | 1.45× |
| 2015-06-30 | $1.53B | $1.24B | $150.00M | (m) | $937.00M | $109.00M | (m) | $168.00M | 1.23× |
| 2015-03-31 | $2.38B | $2.09B | $974.00M | (m) | $949.00M | $106.00M | (m) | $1.04B | 1.14× |
| 2014-12-31 | $1.60B | $1.71B | $192.00M | (m) | $932.00M | $110.00M | (m) | $518.00M | 0.94× |
| 2014-09-30 | $1.56B | $1.19B | $170.00M | (m) | $953.00M | $111.00M | (m) | $22.00M | 1.31× |
| 2014-06-30 | $1.50B | $1.26B | $144.00M | (m) | $963.00M | $109.00M | (m) | $25.00M | 1.20× |
| 2014-03-31 | $1.49B | $1.19B | $144.00M | (m) | $977.00M | $99.00M | (m) | $28.00M | 1.25× |
| 2013-12-31 | $1.38B | $1.13B | $187.00M | (m) | $852.00M | $91.00M | (m) | $212.00M | 1.22× |
| 2013-09-30 | $1.43B | $1.24B | $158.28M | (m) | $920.83M | $85.19M | (m) | (m) | 1.15× |
| 2013-06-30 | $1.47B | $1.29B | $148.34M | (m) | $946.75M | $89.44M | (m) | (m) | 1.14× |
| 2013-03-31 | $1.46B | $1.21B | $133.60M | (m) | $929.97M | $89.82M | (m) | (m) | 1.21× |
| 2012-12-31 | $1.56B | $1.05B | $296.00M | (m) | $867.00M | $93.00M | (m) | $10.00M | 1.49× |
| 2012-09-30 | $1.47B | $1.07B | $191.77M | (m) | $930.73M | $94.51M | (m) | (m) | 1.38× |
| 2012-06-30 | $1.48B | $1.32B | $173.74M | (m) | $941.47M | $90.10M | (m) | (m) | 1.12× |
| 2012-03-31 | $1.52B | $1.53B | $145.44M | (m) | $973.89M | $88.26M | (m) | (m) | 1.00× |
| 2011-12-31 | $1.40B | $1.56B | $164.89M | (m) | $906.46M | $89.13M | (m) | $569.39M | 0.90× |
| 2011-09-30 | $1.40B | $1.76B | $110.83M | (m) | $936.26M | $84.95M | (m) | $750.91M | 0.79× |
| 2011-06-30 | $1.48B | $1.99B | $184.22M | (m) | $929.37M | $87.97M | (m) | $909.67M | 0.74× |
| 2011-03-31 | $2.30B | $1.77B | $994.24M | (m) | $940.36M | $71.74M | (m) | $629.24M | 1.30× |
| 2010-12-31 | $1.61B | $1.21B | $449.30M | (m) | $845.30M | $76.57M | (m) | $349.00M | 1.32× |
| 2010-09-30 | $1.55B | $1.15B | $369.26M | (m) | $884.09M | $73.19M | (m) | $331.53M | 1.35× |
| 2010-06-30 | $1.63B | $995.50M | $447.89M | (m) | $869.64M | $78.43M | (m) | $171.13M | 1.64× |
| 2010-03-31 | $1.65B | $1.08B | $463.24M | (m) | $865.16M | $79.46M | (m) | $170.40M | 1.53× |
| 2009-12-31 | $1.68B | $1.06B | $534.26M | (m) | $827.34M | $91.39M | (m) | $170.51M | 1.59× |
| 2009-09-30 | $1.47B | $990.85M | $247.03M | (m) | $888.29M | $80.86M | (m) | (m) | 1.48× |
| 2009-06-30 | $1.34B | $1.02B | $119.29M | (m) | $896.53M | $79.72M | (m) | (m) | 1.31× |
| 2008-12-31 | $1.50B | $1.22B | $253.95M | (m) | $832.87M | $102.13M | (m) | $5.14M | 1.22× |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LABCORP HOLDINGS INC. (LH) | United States | $25.060B | 22.60 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |